Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,929Revenue (TTM) $M1,609Net Margin (%)15.5Altman Z-Score5.3
Enterprise Value $M4,433EPS (TTM) $4.3Operating Margin %18.4Piotroski F-Score7
P/E(ttm)18.2Beneish M-Score-2.9Pre-tax Margin (%)17.9Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %4.9Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %29.8Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow20.4y-y EBITDA Growth Rate %26.4ROA % (ttm)14.3Higher Current Ratio y-yY
Dividend Yield %--PEG0.6ROE % (ttm)28.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M55.5ROIC % (ttm)27.5Gross Margin Increase y-yY

Gurus Latest Trades with ICLR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ICLRRon Baron 2016-03-31 Reduce-0.05%$66.04 - $77.7
($70.12)
$ 78.8212%Reduce -14.04%931,953
ICLRRon Baron 2015-12-31 Reduce-0.02%$63.87 - $78.14
($71.52)
$ 78.8210%Reduce -4.79%1,084,201
ICLRRon Baron 2015-06-30 Reduce-0.09%$63.29 - $71.66
($67.51)
$ 78.8217%Reduce -22.48%1,138,759
ICLRFirst Eagle Investment 2014-06-30 Sold Out -0.0015%$37.92 - $48.97
($43.22)
$ 78.8282%Sold Out0
ICLRRon Baron 2013-09-30 Add0.05%$36.24 - $40.67
($38.49)
$ 78.82105%Add 25.15%1,280,000
ICLRRon Baron 2013-06-30 Add0.04%$29.2 - $36.22
($32.9)
$ 78.82140%Add 24.31%1,022,800
ICLRMeridian Funds 2013-03-31 Reduce-0.17%$27.25 - $32.91
($29.87)
$ 78.82164%Reduce -33.19%308,000
ICLRRon Baron 2013-03-31 Buy 0.15%$27.25 - $32.91
($29.87)
$ 78.82164%New holding822,800
ICLRMeridian Funds 2012-12-31 Reduce-0.16%$23.46 - $28.54
($26.39)
$ 78.82199%Reduce -28.22%461,000
ICLRMeridian Funds 2012-06-30 Add0.1%$20.51 - $23.23
($21.82)
$ 78.82261%Add 24.87%642,200
ICLRMeridian Funds 2012-03-31 Add0.06%$17.06 - $22.01
($19)
$ 78.82315%Add 25.16%514,300
ICLRFirst Eagle Investment 2011-09-30 Add$16.5 - $25.21
($20.62)
$ 78.82282%Add 36.36%15,000
ICLRMeridian Funds 2011-06-30 Buy 0.24%$21.18 - $25.92
($24.03)
$ 78.82228%New holding351,000
ICLRFirst Eagle Investment 2010-12-31 Add$19.22 - $22.22
($20.61)
$ 78.82282%Add 37.50%11,000
ICLRGeorge Soros 2010-09-30 Sold Out -0.03%$21.7 - $27.69
($24.14)
$ 78.82227%Sold Out0
ICLRFirst Eagle Investment 2010-06-30 Reduce$26.2 - $29.99
($27.9)
$ 78.82183%Reduce -42.86%8,000
ICLRGeorge Soros 2010-03-31 Add$21.61 - $27.27
($24.53)
$ 78.82221%Add 27.15%28,100
ICLRGeorge Soros 2009-12-31 Add0.01%$21.23 - $26.24
($23.21)
$ 78.82240%Add 169.51%22,100
ICLRGeorge Soros 2009-09-30 Buy $20.87 - $24.68
($22.71)
$ 78.82247%New holding8,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ICLR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ICLR: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ICLR :

Quarterly/Annual Reports about ICLR:

    News about ICLR:

    Articles On GuruFocus.com
    Dynamite Comes in Small Packages: 10 Small Caps to Get Explosive Returns Apr 01 2016 
    Probable Gainers Of A European Market Bounce Back Jan 25 2015 
    Meridian Funds Comments on Icon PLC Dec 17 2014 
    Meridian Contrarian Fund 3Q 2014 Commentary Dec 17 2014 
    Baron Funds Comments on ICON PLC Jun 10 2013 
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    Weekly Guru Bargains Highlights: SD, CREE, AMLN, ICLR, CVD Nov 07 2010 

    More From Other Websites
    Edited Transcript of ICLR earnings conference call or presentation 26-Jul-16 1:00pm GMT Jul 26 2016
    ICON PLC Earnings Call scheduled for 9:00 am ET today Jul 26 2016
    Q2 2016 ICON PLC Earnings Release - Time Not Supplied Jul 26 2016
    6:10 am ICON plc reports EPS in-line, revs in-line; reaffirms FY16 EPS guidance, revs guidance Jul 26 2016
    ICON Reports Second Quarter 2016 Results Jul 26 2016
    Icon PLC beats Street 2Q forecasts Jul 26 2016
    Icon PLC beats Street 2Q forecasts Jul 26 2016
    ICON Reports Second Quarter 2016 Results Jul 26 2016
    ICON Reports Second Quarter 2016 Results Jul 26 2016
    Healthcare Earnings Scheduled on Jul 26: CNC, ICLR, UHS Jul 25 2016
    ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting Jul 25 2016
    ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting Jul 25 2016
    ETF’s with exposure to ICON Plc : July 19, 2016 Jul 19 2016
    ETF’s with exposure to ICON Plc : July 1, 2016 Jul 01 2016
    ICON to Acquire Clinical Research Management, Inc. Jun 30 2016
    ICON to Acquire Clinical Research Management, Inc. Jun 30 2016
    ICON Plc :ICLR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 Jun 28 2016
    Healthcare Opportunities in Light of Brexit-Driven Selloff Jun 28 2016
    ICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : June 27, 2016 Jun 27 2016
    ICON: DIA Live to Provide a Digital Window into DIA Conference 2016 Jun 23 2016
    ICON: DIA Live to Provide a Digital Window into DIA Conference 2016 Jun 23 2016
    Coverage initiated on ICON plc by Credit Suisse Jun 21 2016
    ICON and Pfizer Extend Ties, Sign New Agreement Jun 15 2016
    New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical... Jun 15 2016
    New Research from ICON Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical... Jun 15 2016
    ICON Reveals Service Deal With Pfizer Jun 10 2016
    ICON Announces Service Agreement with Pfizer Jun 10 2016
    ICON Announces Service Agreement with Pfizer Jun 10 2016
    ICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : June 1, 2016 Jun 01 2016
    ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research... May 16 2016
    ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research... May 16 2016
    Icon PLC beats 1Q profit forecasts Apr 26 2016
    ICON Reports First Quarter 2016 Results Apr 26 2016
    ICON Reports First Quarter 2016 Results Apr 26 2016
    Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for... Mar 29 2016
    ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance... Mar 08 2016
    Icon PLC tops 4Q profit forecasts Feb 23 2016
    ICON selected by Genomics England to support the largest genome sequencing project of its kind for... Feb 09 2016
    ICON Releases Flex Advantage to Enhance Patient Randomisation and Clinical Supply Management in... Jan 19 2016
    ICON Secures Investment Grade Credit Ratings Jan 05 2016
    ICON Secures Investment Grade Credit Ratings Jan 05 2016
    ICON plc Announces Private Placement of US$350,000,000 of Senior Notes Dec 16 2015
    ICON Accelerates Site Activation Timelines by up to 25% Dec 09 2015
    ICON Acquires PMG Research Inc. Dec 07 2015
    ICON Acquires PMG Research, Inc. Dec 07 2015
    ICON Announces the Appointment of Dr. Steve Cutler to Board of Directors Nov 25 2015
    ICON Partners with iCardiac Technologies to Provide an Earlier and More Precise Method for... Nov 03 2015
    ICON Reports Third Quarter 2015 Oct 27 2015
    Icon PLC beats 3Q profit forecasts Oct 27 2015
    ICON Reports Third Quarter 2015 Oct 27 2015
    ICON Strengthens its Leadership Team in Asia Pacific with Two Key Appointments Oct 22 2015
    ICON Receives Finalist Nomination for the 2015 Scrip Awards Sep 21 2015
    ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up... Sep 10 2015
    Icon PLC beats 2Q profit forecasts Jul 28 2015
    ICON Reports Second Quarter 2015 Jul 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)